The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent

References

• Naruganahalli KS, Lakshmanan M, Dastidar SG, Ray A. Therapeutic potential of Aurora kinase inhibitors in cancer. Curr Opin Investig Drugs 2006; 7:1044 - 1051; PMID: 17209521
   PubMed Web of Science ®Google Scholar
• Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53−/− cells. EMBO J 2002; 21:483 - 492; PMID: 11847097; http://dx.doi.org/10.1093/emboj/21.4.483
   PubMed Web of Science ®Google Scholar
• Nigg EA. Centrosome aberrations: cause or consequence of cancer progression?. Nat Rev Cancer 2002; 2:815 - 825; PMID: 12415252; http://dx.doi.org/10.1038/nrc924
   PubMed Web of Science ®Google Scholar
• Ho CC, Hau PM, Marxer M, Poon RY. The requirement of p53 for maintaining chromosomal stability during tetraploidization. Oncotarget 2010; 1:583 - 595; PMID: 21317454
   PubMed Web of Science ®Google Scholar
• Kawasaki A, Matsumura I, Miyagawa Ji, Ezoe S, Tanaka H, Terada Y, et al. Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells. J Cell Biol 2001; 152:275 - 287; PMID: 11266445; http://dx.doi.org/10.1083/jcb.152.2.275
   PubMed Web of Science ®Google Scholar
• Rojanala S, Han H, Muñoz RM, Browne W, Nagle R, Von Hoff DD, et al. The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer. Mol Cancer Ther 2004; 3:451 - 457; PMID: 15078988
   PubMed Web of Science ®Google Scholar
• Elhajouji A, Cunha M, Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 1998; 13:193 - 198; PMID: 9568594; http://dx.doi.org/10.1093/mutage/13.2.193
   PubMed Web of Science ®Google Scholar
• Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, et al. A p53-dependent mouse spindle checkpoint. Science 1995; 267:1353 - 1356; PMID: 7871434; http://dx.doi.org/10.1126/science.7871434
   PubMed Web of Science ®Google Scholar
• Khan SH, Wahl GM. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res 1998; 58:396 - 401; PMID: 9458079
   PubMed Web of Science ®Google Scholar
• Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998; 18:1055 - 1064; PMID: 9448003
   PubMed Web of Science ®Google Scholar
• Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T, et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2 and Cenp-E to kinetochores. J Cell Biol 2003; 161:267 - 280; PMID: 12719470; http://dx.doi.org/10.1083/jcb.200208091
   PubMed Web of Science ®Google Scholar
• Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 2003; 161:281 - 294; PMID: 12707311; http://dx.doi.org/10.1083/jcb.200208092
   PubMed Web of Science ®Google Scholar
• Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004; 10:262 - 267; PMID: 14981513; http://dx.doi.org/10.1038/nm1003
   PubMed Web of Science ®Google Scholar
• Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci USA 2007; 104:4106 - 4111; PMID: 17360485; http://dx.doi.org/10.1073/pnas.0608798104
   PubMed Web of Science ®Google Scholar
• Nair JS, de Stanchina E, Schwartz GK. The topoisomerase I poison CPT-11 enhances the effect of the Aurora B kinase inhibitor AZD1152 both in vitro and in vivo. Clin Cancer Res 2009; 15:2022 - 2030; PMID: 19276280; http://dx.doi.org/10.1158/1078-0432.CCR-08-1826
   PubMed Web of Science ®Google Scholar
• Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 2006; 66:7668 - 7677; PMID: 16885368; http://dx.doi.org/10.1158/0008-5472.CAN-05-3353
   PubMed Web of Science ®Google Scholar
• Schmidt S, Essmann F, Cirtea IC, Kuck F, Thakur HC, Singh M, et al. The centrosome and mitotic spindle apparatus in cancer and senescence. Cell Cycle 2010; 9:4469 - 4473; PMID: 21088502; http://dx.doi.org/10.4161/cc.9.22.13684
   PubMed Web of Science ®Google Scholar
• Nair JS, Ho AL, Tse AN, Coward J, Cheema H, Ambrosini G, et al. Aurora B kinase regulates the post-mitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780. Mol Biol Cell 2009; 20:2218 - 2228; PMID: 19225156; http://dx.doi.org/10.1091/mbc.E08-08-0885
   PubMed Web of Science ®Google Scholar
• Hoellein A, Pickhard A, von Keitz F, Schoeffmann S, Piontek G, Rudelius M, et al. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Oncotarget 2011; 2:599 - 609; PMID: 21865609
   PubMed Web of Science ®Google Scholar
• Rao B, van Leeuwen IM, Higgins M, Campbel J, Thompson AM, Lane DP, et al. Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget 2010; 1:639 - 650; PMID: 21317459
   PubMed Web of Science ®Google Scholar
• Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004; 36:55 - 62; PMID: 14702041; http://dx.doi.org/10.1038/ng1279
   PubMed Web of Science ®Google Scholar
• Kaestner P, Stolz A, Bastians H. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells. Mol Cancer Ther 2009; 8:2046 - 2056; PMID: 19584233; http://dx.doi.org/10.1158/1535-7163.MCT-09-0323
   PubMed Web of Science ®Google Scholar
• Shimomura T, Hasako S, Nakatsuru Y, Mita T, Ichikawa K, Kodera T, et al. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol Cancer Ther 2010; 9:157 - 166; PMID: 20053775; http://dx.doi.org/10.1158/1535-7163.MCT-09-0609
   PubMed Web of Science ®Google Scholar
• Vitale I, Jemaà M, Senovilla L, Galluzzi L, Rello-Varona S, Metivier D, et al. Involvement of p38alpha in the mitotic progression of p53(−/−) tetraploid cells. Cell Cycle 2010; 9:2823 - 2829; PMID: 20686359; http://dx.doi.org/10.4161/cc.9.14.12254
   PubMed Web of Science ®Google Scholar
• Kufer TA, Silljé HH, Körner R, Gruss OJ, Meraldi P, Nigg EA. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002; 158:617 - 623; PMID: 12177045; http://dx.doi.org/10.1083/jcb.200204155
   PubMed Web of Science ®Google Scholar
• Lampson MA, Kapoor TM. The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat Cell Biol 2005; 7:93 - 98; PMID: 15592459; http://dx.doi.org/10.1038/ncb1208
   PubMed Web of Science ®Google Scholar